John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 3,570 shares at $195.53 ($698K) on 2014-12-11, disclosed to the SEC on 2014-12-15.
Open-market sale of $698k ALXN by EVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |